SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

SARS-CoV-2 disrupts cholesterol metabolism by using its ORF3a protein to sequester cholesterol in lysosomes, reducing BMP levels and optimizing viral survival. This novel mechanism offers insights into long-term metabolic complications of COVID-19.

Elation Health, Surescripts Partner to Boost Medication Affordability

What You Should Know: – Elation Health, a provider of clinical-first technology for primary care, has announced a major expansion of its partnership with Surescripts,

January 23, 2024

Neurocrine’s depression drug passes Phase 2 trial

Neurocrine Biosciences reported that its pill for major depressive disorder reduced scores on a depression severity scale at about one month in a Phase 2

April 24, 2024

Indena’s CDMO services: Health is a joint project – Pharmaceutical Technology

Share this article Credit: ME Image via Shutterstock. Indena offers custom development services by leveraging the expertise of a specialised team that’s devoted to designing

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.